Previous 10 | Next 10 |
ENGLEWOOD, Colo. , Oct. 2, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, tod...
Autolus Therapeutics (NASDAQ: AUTL ) initiated with Buy rating and $26 (99% upside) price target at Needham. More news on: Autolus Therapeutics plc, Edwards Lifesciences Corporation, Elanco Animal Health Incorporated, Healthcare stocks news, Stocks on the move, , Read more ...
Medical science has come a long way from the days when plague doctors wore scary, long-beaked masks and prescribed a steady treatment of leeches and stabbing to cure a head cold. These days, leading American healthcare stocks employ state-of-the-art technology to excel at both saving live...
Editor's note: Seeking Alpha is proud to welcome Florian Buschek as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more » Shares of Zynex...
I have been studying the price movement of stocks that uplist to the NYSE and Nasdaq for almost three years. I look at the price change from six months prior to uplisting to the uplisting price and then the stock price in subsequent quarters. My previous work led me to conclude that there is a...
[Unless otherwise specified, all quotes are drawn from the Q2 2019 earnings call .] Considering the company's history (especially pre-2015), investors had reason to be concerned Zynex ( ZYXI ) would not be able to seize the extraordinary opportunity presented by the exit of its competitors ...
Zynex, Inc. (ZYXI) Q2 2019 Earnings Conference Call July 31, 2019, 04:30 PM ET Company Participants Thomas Sandgaard - Founder, Chairman and CEO Dan Moorhead - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Marc Wiesenberger - B. Riley FBR Yi Chen - ...
We bought Zynex ( ZYXI ) for the SHU portfolio a month or so ago on June 25 and June 27 . Although we could have chosen a better entry point, we have our focus on the long-term with this one (as we have with most of the stocks in the SHU portfolio). The reasons are simple. A quick summa...
ENGLEWOOD, Colo. , July 31, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, ...
ENGLEWOOD, Colo., July 23, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnost...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...
Zynex Reports Second Quarter 2024 Financial Results PR Newswire Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo. , July 25, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the ma...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...